AwardedMLTGoods€816,863
CT2377/2025 - Framework Contract for the supply of Ustekinumab 45mg Solution for Injection, Ustekinumab 90mg Solution for Injection , and Ustekinumab 130mg Concentrate for Solution for Infusion
- Published
- Published 15 December 2025
- Deadline
- Closed 5 February 2026
Overview
A framework contract for the supply of Ustekinumab pharmaceutical products in three formulations (45mg, 90mg solution for injection, and 130mg concentrate for infusion) has been awarded to Mint Health Limited for €239,689.54 on 20 May 2026. The contract was estimated at €816,863 and is now complete.
Key details
- Country
- MLT
- Status
- Awarded
- Category
- Goods
- Estimated value
- €816,863
- Procedure
- Open
- Published
- 15 December 2025
- Deadline
- Closed
Toxins
Award outcome
- Awarded value
- €239,690
- Award date
- 20 May 2026
- Mint Health Limited
Contract ending soon? Skim tracks incumbents and flags recompetes early. Book a demo to set up alerts.
Notice history
Every published notice in this contracting process, newest first.
Contract Award Notice
3 June 2026
Contract Notice
13 January 2026
Contract Notice
7 January 2026
Contract Notice
15 December 2025
Contracting authority
Department of Contracts
Procuring entityFloriana, MLT
Authority website ↗
Get the full picture
AI analysis, bid scoring, and expert strategy for this tender
Skim analyses every tender against your company profile and tells you whether to bid, how to win, and who you are up against.
See which competitors are winning the contracts you're chasing.
15-minute call. We'll pull the win data on your real pipeline and show you what Skim does with it.